Presented by Charles R. Drew University
Meet the Panelists
About the authorDr. Lorelei Mucci, ScD
Professor of Epidemiology at Harvard TH Chan School of Public Health
Dr. Mucci’s major area of research and teaching is cancer epidemiology. She is the Director of the Cancer Epidemiology and Cancer Prevention Program within the Department of Epidemiology at the Harvard T.H. Chan School of Public Health (HSPH). In addition, she is Leader of the Cancer Epidemiology Program at the Dana-Farber/Harvard Cancer Center. After receiving a doctoral degree in epidemiology at the Harvard T.H. Chan School of Public Health she trained as a post-doctoral fellow in cancer epidemiology at the Karolinska Institute, Sweden. At the Karolinska, she gained expertise in using nationwide health registries to examine cancer etiology. For the past 9 years, her primary faculty appointment has been at the Harvard Chan School, where her research uses integrative molecular epidemiology approaches within cohorts in the United States and globally to investigate research questions focused on cancer etiology, mortality, and survivorship. Dr. Mucci has presented basic information on how the COVID-19 vaccines work as well as providing info about the new variant strains, the needs to establish “herd immunity” and provide information on what to expect in the future concerning public health efforts to control the pandemic in the U.S.
About the authorDR. PAUL L. ROBINSON PhD
Director of Charles R. Drew University Medical GIS Laboratory
Dr. Robinson is a medical geographer with extensive experience in bringing concepts theories and methods from spatial science into medical research. He has extensive knowledge and experience applying the principles, theories and methods of GIS to bio-medical research. He is an NIH researcher and director of the CDU Medical GIS laboratory. Recently Dr. Robinson has been researching the uneven geographic spread and disparate impacts of Coronavirus and COVID-19 outcomes. Visit us at http://medgis.cdrewu.edu